Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
In the past, it was considered rather difficult to contest assembly elections without a recognisable chief ministerial candidate’s face as...
Read moreDetails
The Pentagon’s announcement on 2 May to significantly reduce American troop presence in Germany marks a pivotal moment in the...
Read moreDetails
By Aakar Patel If you are normal, you have any number of parties you can support and vote for. There...
Read moreDetails
Americans must have heaved a sigh of relief that a man rushing with a gun and firing shots at the...
Read moreDetails
